This week in Clipboard Health’s Nursing News round up …
US Sets Record COVID-19 Deaths for Second Week
For the second week in a row, the United States set a record for its COVID-19 death rate. By the end of the week, more than 22,000 people died from COVID-19.
Overall, more than 375,000 people have died from COVID-19 since the pandemic started, an average of one out of every 873 residents.
Most States Expand COVID-19 Vaccination Programs
Vaccine rollout across the United States has been slow since the vaccine was approved a month ago. The first phases of vaccine rollout covered health care workers and residents and staff of long-term care facilities.
In response, most states have expanded their vaccination programs to include the next phase of populations, generally people 70 years old and older and those who work in essential services, like education, law enforcement, and emergency response.
Study Finds Pfizer-BioNTech Vaccine Likely to Protect Against Variant COVID-19
A new laboratory study currently waiting peer-review has found that the Pfizer-BioNTech vaccine seems to be able to protect against new COVID-19 variants, including those that have been found in Britain and South Africa.
The study was conducted in a laboratory setting by Pfizer and scientists from the University of Texas Medical Branch.
WHO Experts to Begin Investigation in China on Coronavirus Origins on Thursday
The World Health Organization (WHO) announced that a WHO team of experts will be arriving in China on January 14 to begin their investigation into the origin of the coronavirus.
WHO has been working with China for a long time and was only able to recently gain final approval to enter the country to begin the research.
Moderna Announces Development into Vaccines for Flu, HIV, and Nipah
Moderna announced on Monday that it was beginning development into three new mRNA-based vaccines for the season flu, HIV, and the nipah (NiV) virus.
These new vaccines are in addition to 24 development programs for mRNA vaccines for other diseases; of those 24, 13 vaccines have entered clinical trials.
Medical Studies Round-Up
Here’s a brief round-up of recent medical studies and their findings for you to stay up-to-date with the ever-evolving field of medical research.
- An international trial found no benefit in using COVID-19 blood plasma to treat severely ill COVID-19 patients.
- A new study that looked at more than 1,700 patients from Wuhan, China, found that 76% of patients still had at least one symptom of COVID-19 up to six months later. The most common symptoms were fatigue and difficulty sleeping.
- Scientists find for the first time that non-photosynthetic bacteria have circadian clocks to determine time. The study will help further scientists’ understanding of circadian rhythms in bacteria and may help in the development of medicine as well as other industries, such as agriculture.
COVID-19 in the News
To learn more about the top vaccines, vaccination timelines, potential requirements for health care professionals and facilities, and more, check out our COVID-19 Vaccine Information hub.
Here’s the most recent news from the past week concerning the COVID-19 pandemic.
- The U.S. Centers for Disease Control and Prevention reported that the United States has administered 8,087,322 first doses of COVID-19 vaccines.
- BioNTech sidesteps Germany’s vaccine plan and offers its vaccine to its own workers to protect its supply chain.
- BioNTech and Pfizer increase COVID-19 vaccine dose estimate to 2 billion doses from 1.3 billion for 2021.